The intraocular lens (IOL) market is expected to register a growth rate of nearly 5% during the forecast period, 2018-2023. Intraocular lenses (IOLs) are implantable medical devices used for vision correction. Increasing cases of diabetes and associated cataract and diabetic retinopathy complications are expected to boost the global market. Increase in ocular conditions, such as cataract and diabetic retinopathy, across the world, is a major aspect assisting the market growth.  According to the National Eye Institute, the United States recorded 7.7 million diabetic retinopathy cases and 24 million cataract cases, which is estimated to reach 11.3 million and 38 million, respectively, by 2030.  Geographically, the market studied is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Each region has been divided further into major countries, for which market size and forecast value are provided separately. Other countries in that particular region are covered under the “Rest of that region”, for which the market size and forecast value are provided as a whole.  A holistic study of the market studied has been carried out by incorporating various factors, extending from country-specific demographic conditions and business cycles to market-specific microeconomic influences, which were needed to analyze future trends.  The research uncovers many paradigm shifts in the market studied, in terms of regional competitive advantage and dynamics, primarily with respect to services.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW AND INDUSTRY TRENDS

6. MARKET DYNAMICS

7. MARKET SEGMENTATION

8. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

9. FUTURE OF THE MARKET